Companies that produce generic drugs and APIs are required to self-identify to the FDA for FY2014 under the Generic Drug User Fee Amendments of 2012. The period extends from May 1 to June 1, 2013 and FDA uses the information to determine the cost for application reviews and inspections of companies.  To read more on, click here. Need help with FDA registrations, contact us at 317.899.9341.